Read-Through for Nonsense Mutations in Type XVII Collagen-Deficient Junctional Epidermolysis Bullosa

    Cristina Has, Saliha Beyza Sayar, Shuangshuang Zheng, Esteban Chacón-Solano, Irina Condrat, Ayushi Yadav, Michel Roberge, Fernando Larcher Laguzzi
    TLDR A new therapy for a skin blistering condition has not been developed yet.
    This study explores the use of translational read-through-inducing drugs (TRIDs) to treat junctional epidermolysis bullosa (JEB) caused by nonsense mutations in the COL17A1 gene. Seven patients' keratinocytes were treated with gentamicin, paromomycin, G418, amlexanox, and PTC124. Gentamicin, paromomycin, and G418 showed varying effectiveness in inducing COL17 expression, especially in cells with the p.W464* mutation. Gentamicin significantly altered the expression of 1,118 genes, while paromomycin had a milder impact. The study concludes that aminoglycosides can induce read-through of COL17A1 nonsense mutations, suggesting potential personalized therapy for JEB patients.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 75 results

      community Female AGA - Low Cortisol/Low DHEA

      in Female  7 upvotes 1 year ago
      Female (37) experiencing hair loss for 5 years, tried max dose of spiro and oral + topical minox without success. Discovered low cortisol and low DHEA levels, seeking functional medicine practitioner for help.

      community Sharing what worked for me (PCOS related hair loss)

      in Female  33 upvotes 1 year ago
      A user with PCOS experienced hair loss and found success using a triple dose of O.N.E Omega by Pure Encapsulations after discovering low Omega fatty acids. Biotin provided minimal improvement, but the Omega supplement significantly restored hair.
      [object Object]

      community DUT mesotherapy in Canada, any good references ?

      in Treatment  8 upvotes 1 year ago
      The conversation is about finding reputable clinics in Canada or near the US border that offer DUT mesotherapy for hair loss. The user is seeking recommendations and cost information for these treatments.

      community GT20029 & KX826 Major Updates from Kintor.

      in Research/Science  101 upvotes 2 months ago
      KX826 shows promise as a hair loss treatment with a 10% increase in hair count, but concerns about Kintor's marketing practices and the systemic effects of treatments like GT20029 and RU58841 remain. Users express skepticism and hope, with some preferring traditional treatments like finasteride and minoxidil.

    Similar Research

    5 / 1000+ results